Author(s): Moghal. Roohi Shabreen, S. Sangeetha


DOI: 10.5958/0974-360X.2020.00355.8   

Address: Moghal. Roohi Shabreen, Dr. S. Sangeetha*
Department of Pharmaceutics, SRM Institute of science and technology, Kattankulathur-603203.
*Corresponding Author

Published In:   Volume - 13,      Issue - 4,     Year - 2020

“Ethosomes” are soft vesicles made up of Phospholipids, Ethanol and water. They are “novel carrier system” used for delivery of drugs having low penetration through biological membrane i.e., Skin “Transdermal delivery of drugs” plays a major role in the Ethosomes. In this review we are going to discuss about various applications of ethosomes i.e. Delivery of antibiotic, Delivery of NSAIDS, Anti-cancer, Anti-fungal, Skin cancer, Anti-Acne etc. Ethosomes are loaded with drugs like Indomethacin (NSAIDS), Clotrimazole (Anti-fungal), Raloxifene HCl (Anti-cancer), Fluconazole (Antibiotic) etc. This review explains about the preparation methods used in the preparation of ethosomes such as cold method, Hot method, Injection method, Mechanical dispersion method and Classic methods. Evaluation tests performed in the ethosomes are Drug entrapment efficiency, permeation characteristics, Assay of HPLC, FT-IR studies, stability studies, size analysis, zeta potential etc. Various Penetrtion enhancers like Labrasol, Transcutol, and Terpenes were used in the formulation of ethososmes. Improve the penetration of both lipophilic and hydrophilic drugs through stratum corneum [SC] into deeper layers of the skin very effectively when compared with liposomes. Ethosomes can act as a carrier for large and diverse group of drugs with different physicochemical properties and found a number of applications in pharmaceutical, biotechnological and cosmetic fields. Enhanced delivery of bioactive molecules through the skin and cellular membranes by means of an ethosomal transporter opens numerous confronts and prospects for the research and future development of novel improved therapies. The formulation of ethosomes possesses promising future in effective dermal or transdermal delivery of bioactive agents.

Cite this article:
Moghal. Roohi Shabreen, S. Sangeetha. Ethosomes: A Novel Drug Delivery System And Their Therapeutic Applications -A Review. Research J. Pharm. and Tech 2020; 13(4): 1970-1978. doi: 10.5958/0974-360X.2020.00355.8

Moghal. Roohi Shabreen, S. Sangeetha. Ethosomes: A Novel Drug Delivery System And Their Therapeutic Applications -A Review. Research J. Pharm. and Tech 2020; 13(4): 1970-1978. doi: 10.5958/0974-360X.2020.00355.8   Available on:

1.    Touitou EI. Composition of applying active substance to or through the skin.US Patent 5. 1996; 30: 540 934.
2.    Guy RH. Ethosomes an recent approach in transdermal drug delivery system. Int J Pharm. 1985; 6: 112-116.
3.    Panchagnula R, Pillai O, Nair V and Ramarao P. Transdermal iontophoresis revisisted. Current Opinion in Chem Bio. 2000; 4: 468-473.
4.    Paolino D, Lucania G and Mardente D. Ethosome for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Cont Rel. 2005; 106: 99- 110.
5.    L´opez-Pinto JM, Gonz´alez Rodr´ıguez ML and Rabasco AM. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm. 2005; 298: 1- 12.
6.    Ming C, Xiangli L and Alfred F. Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: In vitro study with finite and infinite dosage application. Int J Pharm. 2011; 408: 223-234.
7.    Vijayakumar MR, Sathali AHA and Arun K. Formulation and evaluation of diclofenac potassium ethosomes. Int J Pharm Pharm Sci. 2010; 2: 82-86.
8.    Guo J, Ping Q, Sun G and Jiao C. Lecithin vesicular carriers for transdermal delivery of cyclosporine A. Int J Pharm. 2000; 194(2): 201‐207.
9.    Maghraby GMM, Williams AC and Barry BW. Oestradiol skin delivery from ultra deformable liposomes: refinement of surfactant concentration. Int J Pharm. 2000; 196(1): 63‐74.
10.    Mishra AD, Khunt DM, Ghayal AH, Patel CN, Shah DR. Formulation and optimization of ethosomes for transdermal delivery of felodipine. Res J Pharm Technol. 2012;5(12):1509–17.
11.    Bhalaria MK, Naik S, Misra AN. Ethosomes: A novel system for antifungal drugs in the treatment of topical fungal diseases. Indian J. Exp. Biol. 2009; 47(5): 368-75.
12.    Bangham A D, Horne R W. Negative Staining of Phospholipids and Their Structural Modification by Surface-Active Agents as Observed in the Electron Microscope. Journal of Molecular Biology. 1964; 8(5): 660-668.
13.    Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes- novel vesicular carriers for enhanced delivery: caracterization and skin penetration properties. J Control Release. 2000; 65: 403-418.
14.    Dubey V, Mishra D, Jain NK. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm. 2007; 67: 398-405.
15.    B. Berner, P. Liu, Alcohols, in: E.W. Smith, H.I. Maibach pathways. Evidence of existence of the follicular (Eds.), Percutaneous Penetration Enhancers, CRC Press, transport pathway taken by lipid vesicles was re- Boca Raton, Fl, 1995; pp. 45–60.
16.    Touitou E, Alkabes M, Dayan N. Ethosomes: Novel lipid vesicular system for enhanced delivery. Pharm. Res. 1997; S14: 305-306.
17.    Anuradha Patel, R.K. Sharma, Mahesh Trivedi, Shivaprakash, Anjana Panicker. Ethosomes: A Novel Tool for Transdermal Drug Delivery. Research J. Pharm. and Tech. 6(8): August 2013; Page 838-841.
18.    J.Y. Fang, T.L. Hwang, Y.L. Huang, C.L. Fang. Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int. J. Pharm. 2006; 310: 131–138.
19.    S. B. Gondkar, Neha R. Patil, R. B. Saudagar. Formulation Development and Characterization of Etodolac Loaded Transethosomes for Transdermal Delivery. Research J. Pharm. and Tech. 2017; 10(9): 3049-3057.
20.    B. Godin, E. Touitou. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Control Release. 2003; 94: 365-379.
21.    M.A. Elsayed, Y.O. Abdallah, F.V. Naggar, N.M. Khalafallah. Lipids vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm. 2006; 332: 1-16.
22.    Gangwar S., Singh S., Garg G. Ethosomes: A Novel Tool for Drug Delivery Through the Skin. Journal of Pharmacy Research. 2010; 3(4): 688-691.
23.    Kumar KP et al. Ethosomes-a priority in transdermal drug delivery. Int J Advan Pharm Sci 2010; 1: 2.
24.    Jain H, Patel J, Joshi K, Patel P, Upadhyay UM. Ethosomes: A Novel Drug Carrier.International Journal of Clinical Practice. 2011; 7:1: 1-4.
25.    Upadhyay N, Mandal S, Bhatia L, Shailesh S, Chauhan P. A Review on Ethosomes: An Emerging Approach for Drug Delivery through the Skin. Recent Research in Science and Technology 2011; 3(7): 19-24.
26.    Sivakranth M, AnjumaAra P, Krishnaveni C, Venkatesh E. Ethosomes: A Novel Vesicular Drug Delivery System. International Journal of Advances in Pharmaceutical Research. 2012; 2(1): 16-27.
27.    Kumar R, Aslam MD, Tripathi A, Prasad D, Chaudhary V, Jain V, Mishra SK, Singh R. Ethosomes: Novel Vesicular Carriers in Transdermal Drug Delivery. Journal of Global Pharma Technology 2010; 2(6): 1-7.
28.    Rathore AR, Khambete H, Jain S. Preparation and Characterization of Repaglinide Loaded Ethosomal Gel for the Treatment of NIDDM. International Journal of Pharmaceutical and Biological Archives. 2013; 4(2): 385-390.
29.    Shahwal V, Samnani A, Dubey B, Bhowmick M. Ethosomes: An Overview. International Journal of Biomedical and Advance Research. 2011; 2: 161-168.
30.    Dubey V, Mishra D and Dutta T. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Cont Rel. 2007; 123: 148- 154.
31.    Nava D and Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomater. 2000; 21: 1879-1885.
32.    Elsayed MMA, Abdallah OY and Viviane FN. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm. 2006; 322: 60-66.
33.    Thong HY, Zhai H and Maibach HI. Percutaneous enhancers: an overview. J skin Pharmacol Physiol. 2007; 2: 1-12.
34.    Bach M and Lippold BC. Percutaneous penetration enhancement and its quantification. Eur J Pharm Biopharm. 1998; 46 :1-3.
35.    Dubey V, Mishra D and Nahar M. Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes. Nanomed Nanotech Biol Med. 2010; 6: 590-596.
36.    Verma P, Pathak K. Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomed Nanotechnol Bio Med. 2012; 8(4): 489-496.
37.    Pandey N. Proniosomes and ethosomes: New prospect in transdermal and dermal drug delivery system. Int J Pharm Sci Resear. 2011; 2(8): 1988-1996.
38.    Saeed G, Arami S (2013). Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes. BioMed res Int. 2013;(6): 616-810.
39.    Tyagi LK et al. Ethosomes: novel vesicular carrier for enhanced transdermal drug delivery system. Bull Pharm Res. 2004; 3(1): 6-13.
40.    Tyagi LK, Kumar S, Maurya SS, Kori ML. Ethosomes novel vesicular carier for enhanced transdermal drug delivery system. Bulletin Pharm Res 2013; 3(1): 6-13.
41.    Sheer A and Chauhan M: Ethosomes as vesicular carrier for enhanced transdermal delivery of Ketoconazole - Formulation and Evaluation. IJPI's Journal of Pharmaceutics and Cosmetology. 2011; 1(3): 1-14.
42.    Shraddha Pandey, Shashi Kiran Misra, Nisha Sharma. Ethosomes- A Novelize Vesicular Drug Delivery System. Research J. Pharm. and Tech. 2017; 10(9): 3223-3232.
43.    Talegaonkar S, Tariq M, Alabood RM. Design and development of o/w nanoemulsion for the transdermal delivery of ondansetron. Bulletin of Pharmaceutical Research. 2011; 1(3): 18- 30.
44.    Vaibhav Dubey, Dinesh Mishra, Jain N.K, Tathagata Dutta, Manoj Nahar, D.K. Saraf. Dermal and transdermal delivery of an antipsoriatic agent via ethanolic liposomes. J.Control. Release. 2007; 123: 148‐154.
45.    Touitou E, Nava Dayan. Carriers for skin delivery of Trihexyphenidyl Hcl: ethosomes vs liposomes. Biomaterials. 2000; 21: 1879‐1885.
46.    Suresh K. Sahu, Alpana Ram.Evaluation of Linezolid Loaded Ethosomes for Treatment of Deep Skin Infections in Diabetic Model. Research J. Pharm. and Tech 2018; 11(7): 3023-3030.
47.    Verma P, Bhandari N, Roy S et al. Ethosomes: A Novel Drug Carrier For Transdermal Drug Delivery. Am J Ethnomed. 2014; 1(4): 226-230.
48.    Christian C et al. Turbiscan Lab® Expert analysis of the stability of ethosomes® and ultradeformable liposomes containing a bilayer fluidizing agent. Colloids Surf B 2009; 72(1): 155-160.
49.    Fang Yi-Ping et al. Cmparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy. Int J pharm. 2008; 356: 144-152.
50.    Yuefeng R, Zheng F, Zhang X et al. In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers. AAPS PharmSciTech. 2008; 9: 860-865.
51.    Rao Y., Zheng F., Zhang X. In-Vitro Percutaneous Permeation and Skin Accumulation of Finasteride Using Vesicular Ethosomal Carriers. AAPS Pharm Sci Tech 2008; 9: 860-865.
52.    Carl S, Jakob TM, Annette G, Klaus EA, Ann-Therese K, Charlotte AJ and Marica BE. A study of the enhanced sensitizing capacity of a contact allergen in lipid vesicle formulations. Toxicol Appl Pharmacol. 2011; 252: 221-227.
53.    PP. Udapurkar, SR. Kamble and KR. Biyani. Ethosomes - Novel Vesicular Carriers For Enhancing Transdermal Drug Delivery. International Journal of Pharmaceutical and Chemical Sciences. 2015; 2277-5005 Vol. 4.
54.    Biju SS, Sushama T and Mishra PR. Vesicular systems: An overview. Ind J Pharma Sci. 2006; 68(2): 141-153.
55.    Gashin Zandi, Farzaneh Lotfipour, Saeed Ghanbarzadeh, Mahsa Medghalchi, Hamed Hamishehkar. A comparative study on the potentials of nanoliposomes and nanoethosomes for Fluconazole delivery. Journal of Drug Delivery Science and Technology. 2018; Volume 44. 264-269.
56.    An K et al. Preparation and In Vitro Evaluation of Simvastatin Ethosome. Artif Cell Blood Sub Biotechnol. 2011; 39: 347–350.
57.    Dave1 V et al. Ethosome for Enhanced Transdermal Drug Delivery of Aceclofenac. Int J Drug Del. 2010; 2: 81-92.
58.    Jobin Jose, Shweta Shetty, Sandeep D S, Prashanth Nayak. Ethosomes as a Promising Delivery Carrier for Herbal Drugs: Recent Developments. Research J. Pharm. and Tech 2018; 11(7): 3197-3200.
59.    Pajaree Sakdiset, Thanaporn Amnuaikit, Wiwat Pichayakorn, Sirirat Pinsuwan. Formulation development of ethosomes containing indomethacin for transdermal delivery. Journal of Drug Delivery Science and Technology. 2019; Pages 760-768.
60.    Rahul GS et al. Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: A comparative assessment. Saudi Pharm J. 2012; 20: 161–170.
61.    Sarat CC et al. Comparative evaluation of sonicated and un-sonicated ethosomes containing Ketoconazole. Int J Advan Pharm Bio Chem. 2012; 1(1):15- 20.
62.    Sara M. Abdel Samie, Amany O. Kamel, Omaima A.Sammour, Shady M.Ibrahim. Terbinafine hydrochloride nanovesicular gel: In vitro characterization, ex vivo permeation and clinical investigation. European Journal of Pharmaceutical Sciences. 2016; Volume 88. Pages 91-100.
63.    Syed Mahmood, Uttam Kumar Mandal, Bappaditya Chatterjee. Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation. International Journal of Pharmaceutics. 2018; Pages 36-46.
64.    Tunyaluk Limsuwan, Prapaporn Boonme, Pasarat Khongkow, and Thanaporn Amnuaikit. Ethosomes of Phenylethyl Resorcinol as Vesicular Delivery System for Skin Lightening Applications. BioMed Research International. 2017; 12 pages.
65.    JiesiXie, YujieJi, WeiXue, Dong Ma, Yunfeng Hu. Hyaluronic acid-containing ethosomes as a potential carrier for transdermal drug delivery. Colloids and Surfaces B: Biointerfaces. 2018; 323-329.
66.    Guiling Li, Yating Fan, Chao Fan, Xinru Li, Xiaoning Wang, Mei Li, Yan Liu. Tacrolimus-loaded ethosomes: Physicochemical characterization and in vivo evaluation. European Journal of Pharmaceutics and Biopharmaceutics. 2012; 49-57.
67.    Thasleem Moolakkadath, Mohd. Aqil, Abdul Ahad, Syed SarimImam, Arshiya Praveen, Yasmin Sultana, Mohd Mujeeb, ZeenatIqbal. Fisetin loaded binary ethosomes for management of skin cancer by dermal application on UV exposed mice. International Journal of Pharmaceutics. 2019; 78-91.
68.    Inayat B. Pathan, Bhaktraj P. Jaware, Santosh Shelke, Wahid Ambekar. Curcumin loaded ethosomes for transdermal application: Formulation, optimization, in-vitroand in-vivo study. Journal of Drug Delivery Science and Technology. 2018; 49-57.
69.    Joo-Eun Kim, Ga-Hui Oh, Gi-Hyun Jang, Yu-Mi Kim, Young-Joon Park. Transformer-ethosomes with palmitoyl pentapeptide for improved transdermal delivery. Journal of Drug Delivery Science and Technology. 2019; 460-467.
70.    Kim S and Chien YW. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release. 1996; 40: 67-76.
71.    Spruance SL and Semin. The natural history of recurrent oral facial herpes simplex virus infection. Dermatol. 1992; 11: 200-206.
72.    Verma DD and Fahr A. Synergistic penetration effect of ethanol and phospholipids on the topical delivery of Cyclosporin A. J Control Release. 2004; 97: 55-66.
73.    Touitou E, Godin B and Dayan N. Intracellular delivery mediated by an ethosomal carrier. Biomater. 2001; 22: 3053-3059.
74.    Esposito E, Menegatti E and Cortesi R. Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study. J Cosmet Sci. 2004;5 5: 253-264.
75.    Fu Y, Hsieh J, Guo J and Kunicki J. Antiinflammatory efficacy of Licochalcone A: correlation of clinical potency and in vitro effects. Biochem Biophys Res Commun. 2004; 322: 263- 270.
76.    Syed Mahmood, S Uttam Kumar Mandal, Bappaditya Chatterjee . Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation. International Journal of Pharmaceutics Volume 542, Issues 1–2, 5 May 2018; Pages 36-46.
77.    Inayat B. Pathan, Bhaktraj P. Jaware, Santosh Shelke, Wahid Ambekar. Curcumin loaded ethosomes for transdermal application: Formulation, optimization, in-vitroand in-vivo study. Journal of Drug Delivery Science and Technology Volume 44, April 2018; Pages 49-57.
78.    Guiling Lia Yating Fanb Chao Fanb Xinru Lib Xiaoning Wangb Mei Lia Yan Liub. Tacrolimus-loaded ethosomes: Physicochemical characterization and in vivo evaluation. European Journal of Pharmaceutics and Biopharmaceutics Volume 82, Issue 1, September 2012; Pages 49-57.
79.    Monisha C, GNK. Ganesh, Mythili L, Kayalvizhi Radhakrishnan. A Review on Ethosomes for Transdermal Application. Research J. Pharm. and Tech. 2019; 12(7): 3133-3143.
80.    Amala Maxwell, Sneh Priya. Nanosized Ethosomes – A Promising Vesicular Drug Carrier for Transdermal Drug Delivery. Research J. Pharm. and Tech 2019; 12(2):876-880.
81.    R.B. Saudagar, S. Samuel. Ethosomes: Novel noninvasive carrier for Transdermal Drug Delivery. Asian J. Pharm. Tech. 2016; 6(2): 135-138.
82.    Maurya SD, Prajapati SK, Gupta AK Saxena GK, Dhakar RC, Formulation Development and Evaluation of Ethosome of Stavudine. Indian J.Pharm. Educ. Res. 2010; 44(1): 102-108.
83.    Ashish D. Mishra, Dignesh M. Khunt, Aakash H Ghayal, C N Patel, Dinesh R. Shah. Formulation and Optimization of Ethosomes for Transdermal Delivery of Felodipine. Research J. Pharm. and Tech. 5(12): Dec. 2012; Page 1509-1517.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available